Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study assesses anti-SARS-CoV-2 antibody response to mRNA-1273 vaccination over time

A new study has assessed the antibody responses to the mRNA-1273 Moderna vaccine over time.

31 Jan 2022

Observational study reveals continuing inequality in COVID-19 mortality in England and Wales

Recently, the same group of researchers refined their earlier analysis by using new data sets to determine deaths due to COVID-19 instead of including deaths involving COVID-19 in small areas. This study has been posted to the medRxiv* preprint server.

31 Jan 2022

BA.2 sublineage of Omicron shows increased immune evasion and transmission

Recently, researchers from the University of Copenhagen have been investigating the spread of two sublineages of the Omicron variant among Danish households.

31 Jan 2022

Response to COVID-19 vaccine booster in seronegative kidney transplant recipients

Modification of vaccination strategies is needed to improve the immune response to SARS-CoV-2 vaccination in kidney transplant recipients (KTRs).

31 Jan 2022

Study finds limited evidence for IL-1 blockers in treating COVID-19

Researchers assess the effectiveness and safety outcomes of interleukin-1 blocking agents in the treatment of COVID-19.

31 Jan 2022

Research shows rapid antigen tests can detect SARS-CoV-2 variants, including Omicron

Researchers determined the analytical sensitivity of a CE-marked fast antigen with the SARS-CoV-2 Omicron, Delta, Alpha, and Gamma variants.

31 Jan 2022

Yellow fever vaccine-vectored YF-S0 as a potent COVID-19 vaccine candidate

In a new study, a team of researchers developed YF-S0, an exceptionally potent COVID-19 vaccine candidate using live-attenuated yellow fever vaccine YF17D as a vector.

31 Jan 2022

3C-like protease inhibitor clinical candidate, S-217622, as a treatment for SARS-CoV-2

In a new study, a team of researchers discovered S-217622, a non-covalent SARS-CoV-2 3C-like protease (3CLpro) inhibitor clinical candidate for the treatment of COVID-19.

31 Jan 2022

Three exposures to SARS-CoV-2 spike protein can induce robust neutralizing antibodies against variants

In a new study, scientists revealed that three consecutive exposures SARS-CoV-2 spike protein through infection, vaccination, or both can induce strong neutralizing antibodies against a wide variety of viral variants, including omicron.

31 Jan 2022

How many lives would vaccine sharing have saved?

In a new study, researchers have been investigating different COVID-19 vaccine sharing simulations, and how they would affect affect global mortality.

31 Jan 2022

Impact of media dissemination on the use of fluvoxamine against COVID-19

In a new study, researchers examined the changes in the total number of fluvoxamine tablets that were dispensed across retail pharmacies in the U.S.

31 Jan 2022

Evaluating clinical outcomes and viral loads of SARS-CoV-2 Delta and Omicron infections

The current study showed a marked decrease in disease severity with Omicron compared to the Delta variant.

31 Jan 2022

Estimating the impending endemic seasonality of SARS-CoV-2 in global population centers

A new study uses long-term data on the incidence of circulating coronaviruses and estimates the endemic seasonality of SARS-CoV-2 in global population centers.

31 Jan 2022

Nucleocapsid antigen found to be a sensitive biomarker for acute COVID-19 infection

In a new study, researchers found that nucleocapsid antigen in the blood (antigenemia) is a sensitive and specific biomarker for acute coronavirus disease 2019 infection.

31 Jan 2022

Prion-like domains in SARS-CoV-2 RBD and ACE2 play important functional roles in viral adhesion and entry

Scientists have recently detected and analyzed viral PrDs in the S protein of SARS-CoV-2, which are the novel regulators of virion assembly.

31 Jan 2022

Protection provided to children through parental vaccination with the BNT162b2 vaccine

In a new study published in Science, scientists estimated the protection provided to children by means of parental vaccination with the BNT162b2 vaccine.

31 Jan 2022

Patient-reported impact of having surgery delayed during the COVID-19 pandemic

Researchers recently published a study to address this knowledge gap and understand the scope of the personal impact on patients and their daily lives due to delayed surgeries.

31 Jan 2022

Vaccine hypersensitivity in children

A new paper published in Pediatric Allergy and Immunity provides a useful overview of such reactions in relation to pediatric vaccines.

31 Jan 2022

Binding and conformational properties of the SARS-CoV spike protein and hACE2 complex

A new paper in the journal Molecules describes this in molecular terms, comparing SARS-CoV-2 with an earlier highly pathogenic coronavirus, SARS-CoV.

31 Jan 2022

Patients undergoing neurosurgical operations with concomitant COVID-19 infection have higher rates of perioperative complications

This unique paper compares neurosurgical patients with COVID-19 for perioperative complications to those without COVID-19.

31 Jan 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study assesses anti-SARS-CoV-2 antibody response to mRNA-1273 vaccination over time

Observational study reveals continuing inequality in COVID-19 mortality in England and Wales

BA.2 sublineage of Omicron shows increased immune evasion and transmission

Response to COVID-19 vaccine booster in seronegative kidney transplant recipients

Study finds limited evidence for IL-1 blockers in treating COVID-19

Research shows rapid antigen tests can detect SARS-CoV-2 variants, including Omicron

Yellow fever vaccine-vectored YF-S0 as a potent COVID-19 vaccine candidate

3C-like protease inhibitor clinical candidate, S-217622, as a treatment for SARS-CoV-2

Three exposures to SARS-CoV-2 spike protein can induce robust neutralizing antibodies against variants

How many lives would vaccine sharing have saved?

Impact of media dissemination on the use of fluvoxamine against COVID-19

Evaluating clinical outcomes and viral loads of SARS-CoV-2 Delta and Omicron infections

Estimating the impending endemic seasonality of SARS-CoV-2 in global population centers

Nucleocapsid antigen found to be a sensitive biomarker for acute COVID-19 infection

Prion-like domains in SARS-CoV-2 RBD and ACE2 play important functional roles in viral adhesion and entry

Protection provided to children through parental vaccination with the BNT162b2 vaccine

Patient-reported impact of having surgery delayed during the COVID-19 pandemic

Vaccine hypersensitivity in children

Binding and conformational properties of the SARS-CoV spike protein and hACE2 complex

Patients undergoing neurosurgical operations with concomitant COVID-19 infection have higher rates of perioperative complications

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Newsletters you may be interested in